OpenAI's new GPT-4V release supports image uploads — creating a whole new attack vector making large language models (LLMs) vulnerable to multimodal injection image attacks. Attackers can embed ...
Supplementary biologics license application planned for submission to the U.S. Food and Drug Administration in the first quarter of 2025 “All currently FDA-approved anti-VEGF therapies for retinal ...
If approved, EYLEA HD would be the first and only treatment for RVO indicated for up to every 8-week dosing after an initial monthly dosing period – halving the number of injections that are indicated ...